Phase 3 study

AbbVie Wins European Commission Approval for MAVIRET in Acute Hepatitis C

AbbVie has announced that the European Commission has approved MAVIRET® (glecaprevir/pibrentasvir) for the treatment of acute hepatitis C virus infection…